November 9 – 11, 2026
BIO-Europe 2026
OMEICOS Announces Formation of Inaugural Clinical Advisory Board
OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology
OMEICOS Secures Continued BMBF Support with New €1.7M Research Grant to Advance its Novel Approach to Treat Cardiovascular Diseases
OMEICOS Announces First Closing of €8.3 Million Series B Financing Round and the Initiation of Phase 1 Clinical Trial
OMEICOS Receives BMBF Research Grant to Advance its Novel Approach to Treat Atrial Fibrillation
OMEICOS Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation